GFAP and medulloblastoma: We investigated the role of AMPKα2 in vivo in medulloblastoma using the [GFAP-tTA;TRE-SmoA1] genetically engineered mouse model of SHH-driven medulloblastoma [35,36] in combination with the AMPKα2 KO mouse [37].